natgillin/translations-raw huggingface dataset:
It has appeared from the various examinations made that plant protection products containing tefluthrin may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo teflutrin, lahko pričakuje, da bodo na splošno izpolnjevala zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to approve tefluthrin in accordance with Regulation (EC) No 1107/2009.
Zato je primerno, da se teflutrin v skladu z Uredbo (ES) št. 1107/2009 odobri.
Without prejudice to the conclusion that tefluthrin should be approved, it is, in particular, appropriate to require further confirmatory information.
Brez poseganja v sklep, da je treba teflutrin odobriti, je še zlasti primerno zahtevati dodatne podatke potrditvene narave.
A reasonable period should be allowed to elapse before approval in order to permit Member States and the interested parties to prepare themselves to meet the new requirements which will result from the approval.
Pred odobritvijo je treba določiti primeren rok, da se bodo države članice in zainteresirane strani lahko pripravile na izpolnjevanje novih zahtev, ki bodo nastale z odobritvijo.
Without prejudice to the obligations defined by Regulation (EC) No 1107/2009 as a consequence of the approval taking into account the specific situation created by the transition from Directive 91/414/EEC to Regulation (EC) No 1107/2009, the following should, however, apply.
Brez poseganja v obveznosti iz Uredbe (ES) št. 1107/2009, ki izhajajo iz odobritve, in ob upoštevanju posebnega položaja, ki je nastal s prehodom od Direktive 91/414/EGS k Uredbi (ES) št. 1107/2009, je treba upoštevati naslednje.
Member States should be allowed a period of 6 months after approval to review authorisations of plant protection products containing tefluthrin.
Državam članicam je treba po odobritvi omogočiti šestmesečno obdobje, da pregledajo registracije fitofarmacevtskih sredstev, ki vsebujejo teflutrin.
Member States should, as appropriate, vary, replace or withdraw existing authorisations in accordance with the provisions of Directive 91/414/EEC.
Države članice morajo veljavne registracije v skladu z določbami Direktive 91/414/EGS po potrebi spremeniti, nadomestiti ali preklicati.
By way of derogation from the above deadline, a longer period should be provided for the submission and assessment of the update of the complete Annex III dossier, as set out in Directive 91/414/EEC of each plant protection product for each intended use in accordance with the uniform principles.
Z odstopanjem od navedenega roka je treba določiti daljše obdobje za predložitev in oceno celotne posodobljene dokumentacije iz Priloge III za vsako fitofarmacevtsko sredstvo in za vsako nameravano uporabo po enotnih načelih iz Direktive 91/414/EGS.
In accordance with Article 13(4) of Regulation (EC) No 1107/2009 the Annex to Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances [10] should be amended accordingly.
V skladu s členom 13(4) Uredbe (ES) št. 1107/2009 je treba ustrezno spremeniti Prilogo k Izvedbeni uredbi Komisije (EU) št. 540/2011 z dne 25. maja 2011 o izvajanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta glede seznama registriranih aktivnih snovi [10].
The active substance tefluthrin, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov teflutrin, kot je opredeljena v Prilogi I, je odobrena v skladu s pogoji iz navedene priloge.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing tefluthrin as an active substance by 30 June 2012.
Države članice v skladu z Uredbo (ES) št. 1107/2009 do 30. junija 2012 po potrebi spremenijo ali prekličejo veljavne registracije fitofarmacevtskih sredstev, ki vsebujejo teflutrin kot aktivno snov.
By that date they shall in particular verify that the conditions in the Annex I to this Regulation are met, with the exception of those identified in Part B of the column on specific provisions of that Annex, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to Directive 91/414/EEC in accordance with the conditions of Article 13(1) to (4) of that Directive and Article 62 of Regulation (EC) No 1107/2009.
Do navedenega datuma morajo zlasti preveriti, ali so izpolnjeni pogoji iz Priloge I k tej uredbi, z izjemo tistih iz dela B stolpca o posebnih določbah navedene priloge, in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k Direktivi 91/414/EGS v skladu s pogoji iz člena 13(1) do (4) navedene direktive ter člena 62 Uredbe (ES) št. 1107/2009.
By way of derogation from paragraph 1, for each authorised plant protection product containing tefluthrin as either the only active substance or as one of several active substances all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 31 December 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account Part B of the column on specific provisions of Annex I to this Regulation.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje teflutrin kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo k Izvedbeni uredbi (EU) št. 540/2011, in najpozneje do 31. decembra 2011 v skladu z enotnimi načeli iz člena 29(6) Uredbe (ES) št. 1107/2009 na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k Direktivi 91/414/EGS, in ob upoštevanju dela B stolpca o posebnih določbah Priloge I k tej uredbi ponovno ocenijo sredstvo.
in the case of a product containing tefluthrin as the only active substance, where necessary, amend or withdraw the authorisation by 31 December 2015 at the latest; or
če sredstvo vsebuje teflutrin kot edino aktivno snov, najpozneje do 31. decembra 2015 po potrebi spremenijo ali prekličejo registracijo ali
in the case of a product containing tefluthrin as one of several active substances, where necessary, amend or withdraw the authorisation by 31 December 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or substances, whichever is the latest.
če sredstvo vsebuje teflutrin kot eno od več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. decembra 2015 ali do datuma, določenega za tako spremembo ali preklic v ustreznih aktih, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS oziroma s katerimi so bile zadevne snovi odobrene, pri čemer se upošteva poznejši datum.
The line concerning tefluthrin in the Annex to Decision 2008/934/EC is deleted.
V Prilogi k Odločbi 2008/934/ES se črta vrstica o teflutrinu.
European Food Safety Authority; Conclusion on the peer review of the pesticide risk assessment of the active substance tefluthrin.
[8] Evropska agencija za varnost hrane; Sklep o strokovnem pregledu ocene tveganja pesticidov za aktivno snov teflutrin.
[67 pp.]. doi:10.2903/j.efsa.2010.1592.
[67 str.]. doi:10.2903/j.efsa.2010.1592.
OJ L 153, 11.6.2011, p. 1
UL L 153, 11.6.2011, str. 1.
Conditions of approval as active substance under Regulation (EC) No 1107/2009:
Pogoji za odobritev kot aktivne snovi v skladu z Uredbo (ES) št. 1107/2009:
CAS No: 79538-32-2
št. CAS: 79538-32-2
CIPAC No: 451
št. CIPAC: 451
2,3,5,6-tetrafluoro-4-methylbenzyl (1RS, 3RS)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate
2,3,5,6-tetrafluoro-4-methylbenzyl (1RS,3RS)-3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate
Tefluthrin is a 1:1 mixture of Z-(1R, 3R) and Z-(1S, 3S) enantiomers.
Teflutrin je mešanica enantiomerov Z-(1R, 3R) in Z-(1S, 3S) v razmerju 1 : 1.
Hexachlorobenzene: not more than 1 mg/kg
heksaklorobenzen: ne več kot 1 mg/kg
These facilities shall apply the best available techniques in order to exclude the release of dust clouds during storage, transport and application.
Ti objekti uporabljajo najboljše razpoložljive tehnike, da se čim bolj zmanjša izpust prahu med skladiščenjem, prevozom in uporabo.
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on tefluthrin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 17 June 2011 shall be taken into account.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu teflutrina in zlasti dodatka I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 17. junija 2011.
the operators and workers safety and include among the authorised conditions of use the application of adequate personal protective equipment as well as respiratory protective equipment,
varnost izvajalcev in delavcev ter med registrirane pogoje uporabe vključijo uporabo ustrezne osebne zaščitne opreme ter opreme za zaščito dihal,
Risk mitigation measures should be applied to grant a high degree of incorporation in soil and avoidance of spillage,
Ukrepi za zmanjšanje tveganja se morajo uporabljati, da se zagotovi visoka stopnja vključenosti v tla in se prepreči izlitje,
ensure that the label of treated seed includes the indication that the seeds were treated with tefluthrin and sets out the risk mitigation measures provided for in the authorisation.
to, da zagotovijo, da etiketa tretiranih semen vključuje označbo, da so bila semena tretirana s teflutrinom, in navaja ukrepe za zmanjšanje tveganja, določene v registraciji.
the specification of the technical material, as commercially manufactured;
specifikaciji tehničnega materiala v tržni proizvodnji;
a validated analytical method for water;
potrjeni analitski metodi za vodo;
the possible environmental impact of the preferential degradation/conversion of the isomers and an estimation of the relative toxicity and risk assessment for the workers.
možnem vplivu preferenčnega razpada/pretvorbe izomerov na okolje in oceni relativne toksičnosti ter oceni tveganja za delavce.
The applicant shall submit to the Commission, the Member States and the Authority the information set out in point (1) by 30 June 2012, the information set out in point (2) by 31 December 2012, and the information set out in point (3) 2 years after the adoption of a specific guidance document on evaluation of isomers mixture.
Vlagatelj Komisiji, državam članicam in Agenciji predloži informacije iz točke 1 do 30. junija 2012, informacije iz točke 2 do 31. decembra 2012 in informacije iz točke 3 dve leti po sprejetju posebnih smernic za oceno mešanic izomerov.
In Part B of the Annex to Implementing Regulation (EU) No 540/2011 the following entry is added:
V delu B Priloge k Izvedbeni uredbi (EU) št. 540/2011 se doda naslednji vnos:
The applicant shall submit to the Commission, the Member States and the Authority the information set out in point (1) by 30 June 2012, the information set out in point (2) by 31 December 2012, and the information set out in point (3) 2 years after the adoption of a specific guidance document on evaluation of isomers mixture.’
Vlagatelj Komisiji, državam članicam in Agenciji predloži informacije iz točke 1 do 30. junija 2012, informacije iz točke 2 do 31. decembra 2012 in informacije iz točke 3 dve leti po sprejetju posebnih smernic za oceno mešanic izomerov.“
Decision 2008/934/EC provides for the non-inclusion of tefluthrin and the withdrawal of authorisations for plant protection products containing that substance by 31 December 2011.
Odločba 2008/934/ES določa nevključitev teflutrina in preklic registracije fitofarmacevtskih sredstev, ki vsebujejo navedeno snov, do 31. decembra 2011.
It is necessary to delete the line concerning tefluthrin in the Annex to that Decision.
V Prilogi k navedeni odločbi je treba črtati vrstico o teflutrinu.
Commission Implementing Regulation (EU) No 801/2011
Izvedbena uredba Komisije (EU) št. 801/2011
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down the animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption [1], and in particular the introductory phrase of Article 8, the first subparagraph of Article 8(1), and Article 8(4), thereof,
ob upoštevanju Direktive Sveta 2002/99/ES z dne 16. decembra 2002 o predpisih v zvezi z zdravstvenim varstvom živali, ki urejajo proizvodnjo, predelavo, distribucijo in uvoz proizvodov živalskega izvora, namenjenih prehrani ljudi [1], in zlasti uvodnega stavka člena 8, prvega pododstavka člena 8(1) in člena 8(4) Direktive,
Regulation (EU) No 206/2010 provides that consignments of fresh meat intended for human consumption are to be imported into the Union only if they come from the third countries, territories or parts thereof listed in Part 1 of Annex II to that Regulation for which there is a model veterinary certificate corresponding to the consignment concerned listed in that Part.
Uredba (EU) št. 206/2010 določa, da se pošiljke svežega mesa, namenjenega za prehrano ljudi, v Unijo uvozijo le, če prihajajo iz tretjih držav, njihovih ozemelj ali delov iz dela 1 Priloge II k navedeni uredbi, za katere v navedenem delu obstaja vzorec veterinarskega spričevala, ki ustreza zadevni pošiljki.
Four parts of the territory of Botswana are listed in Part 1 of Annex II to Regulation (EU) No 206/2010 as regions from which imports of fresh de-boned and matured meat from ungulates into the Union are authorised.
Štirje deli ozemlja Bocvane so navedeni v delu 1 Priloge II k Uredbi (EU) št. 206/2010 kot regije, iz katerih se odobri uvoz svežega izkoščenega in zorjenega mesa kopitarjev v Unijo.
Those regions consist of a number of veterinary disease control zones.
Navedene regije so sestavljene iz številnih območji z boleznimi pod veterinarskim nadzorom.
On 5 May 2011, Botswana informed the Commission of a suspicion of foot-and-mouth disease based on clinical signs found in eight cattle on a farm.
Bocvana je 5. maja 2011 obvestila Komisijo o sumu izbruha slinavke in parkljevke na podlagi kliničnih znakov pri osmih govedih na kmetiji.
The outbreaks were confirmed, and notified to the Commission, on 11 May 2011 based on the isolation of a SAT2 foot-and-mouth disease virus.
Izbruhe so potrdili 11. maja 2011 na podlagi osamitve virusa slinavke in parkljevke SAT2 in o njih takrat obvestili Komisijo.
The outbreaks occurred in the veterinary disease control zone 6, which forms part of one of the four parts of the territory of Botswana from which imports of fresh de-boned and matured meat from ungulates into the Union are authorised.
Bolezen se je pojavila na območju pod veterinarskih nadzorom 6, ki je del enega od štirih delov ozemlja Bocvane, iz katerega se odobri uvoz svežega izkoščenega in zorjenega mesa kopitarjev v Unijo.
Due to the risk of introduction of foot-and-mouth disease through imports into the Union of fresh meat from species susceptible to that disease, and considering the guarantees given by Botswana allowing for regionalisation of the country, the authorisation of Botswana to export fresh de-boned and matured meat from ungulates into the Union from the affected part of its territory should be suspended as from 11 May 2011, the date of confirmation of the outbreaks of foot-and-mouth disease.
Zaradi tveganja vnosa slinavke in parkljevke z uvozom svežega mesa vrst, dovzetnih za navedeno bolezen, v Unijo in jamstev Bocvane ob upoštevanju regionalizacije države je treba dovoljenje za izvoz svežega izkoščenega in zorjenega mesa kopitarjev iz prizadetih delov ozemlja Bocvane v Unijo začasno preklicati od 11. maja 2011, datuma potrditve izbruhov parkljevke in slinavke.
Annex II to Regulation (EU) No 206/2010 should therefore be amended accordingly.
Prilogo II k Uredbi (EU) št. 206/2010 je zato treba ustrezno spremeniti.
In Part 1 of Annex II to Regulation (EU) No 206/2010 the entry for Botswana is replaced by the following:
Del 1 Priloge II k Uredbi (EU) št. 206/2010, vnos za Bocvano se nadomesti z naslednjim:
‘BW – Botswana
„BW – Bocvana
11 May 2011
11. maj 2011
7 March 2002
7. marec 2002
The veterinary disease control zone 12
Območje z boleznimi pod veterinarskim nadzorom št. 12
20 October 2008
20. oktober 2008
20 January 2009
20. januar 2009
The veterinary disease control zone 4a, except the intensive surveillance buffer zone of 10 km along the boundary with the foot-and-mouth disease vaccination zone and wildlife management areas
Območje z boleznimi pod veterinarskim nadzorom št. 4a, razen zaščitnega območja intenzivnega nadzora širine 10 km ob meji z območjem, kjer se opravlja cepljenje proti slinavki in parkljevki, ter z območji upravljanja prosto živečih živali
18 February 2011’
18. februar 2011“
Commission Implementing Regulation (EU) No 802/2011
Izvedbena uredba Komisije (EU) št. 802/2011
This Regulation shall enter into force on 10 August 2011.
Ta uredba začne veljati 10. avgusta 2011.
Council Implementing Regulation (EU) No 803/2011
Izvedbena uredba Sveta (EU) št. 803/2011
repealing the countervailing duty on imports of certain broad spectrum antibiotics originating in India and terminating the proceeding in respect of such imports, following review pursuant to Article 18(2) of Council Regulation (EC) No 597/2009
o odpravi izravnalne dajatve na uvoz nekaterih antibiotikov širokega spektra s poreklom iz Indije in o zaključku postopka v zvezi s takim uvozom po pregledu v skladu s členom 18(2) Uredbe (ES) št. 597/2009
Having regard to Council Regulation (EC) No 597/2009 of 11 June 2009 on protection against subsidised imports from countries not members of the European Community [1], (the basic Regulation), and in particular Article 18 thereof,
ob upoštevanju Uredbe Sveta (ES) št. 597/2009 z dne 11. junija 2009 o zaščiti proti subvencioniranemu uvozu iz držav, ki niso članice Evropske skupnosti [1] (v nadaljnjem besedilu: osnovna uredba), in zlasti člena 18 Uredbe,
In May 2005, following a combined expiry and interim review (the combined review), the Council, by Regulation (EC) No 713/2005 [2], imposed a definitive countervailing duty on imports of certain broad spectrum antibiotics, namely amoxicillin trihydrate, ampicillin trihydrate and cefalexin not put up in measured doses or in forms or packing for retail sale (the product concerned) currently falling within CN codes ex29411000 and ex29419000 originating in India.
Svet je maja 2005 po skupnem pregledu zaradi izteka ukrepa in vmesnem pregledu (v nadaljnjem besedilu: skupni pregled) z Uredbo (ES) št. 713/2005 [2] uvedel dokončno izravnalno dajatev na uvoz določenih antibiotikov širokega spektra, in sicer za amoksicilin trihidrat, ampicilin trihidrat in cefaleksin, ki niso predloženi v odmerkih ali v oblikah ali v pakiranjih za prodajo na drobno (v nadaljnjem besedilu: zadevni izdelek) in ki se trenutno uvrščajo pod oznaki KN ex29411000 in ex29419000, s poreklom iz Indije.
The measures took the form of an ad valorem duty ranging from 17,3 % to 32 %.
Ukrepi so bili v obliki dajatve ad valorem v višini od 17,3 % do 32 %.
The original measures had been imposed by Regulation (EC) No 2164/98 [3].
Prvotni ukrepi so bili uvedeni z Uredbo Sveta (ES) št. 2164/98 [3].
Following a partial interim review, the Council, by Regulation (EC) No 1176/2008 [4], amended the countervailing duty rate applicable to one Indian exporter.
Svet je po delnem vmesnem pregledu z Uredbo (ES) št. 1176/2008 [4] spremenil stopnjo izravnalne dajatve za enega indijskega izvoznika.
Following the publication of a notice of impending expiry [5] of the definitive measures in force, the Commission received a request for the initiation of an expiry review of Council Regulation (EC) No 713/2005 pursuant to Articles 18(2) of the basic Regulation, from two Union producers: DSM and Sandoz (the applicants), representing a major proportion, in this case more than 50 % of the total Union production of certain broad spectrum antibiotics.
Komisija je po objavi obvestila o bližnjem izteku veljavnosti dokončnih ukrepov [5] od dveh proizvajalcev Unije prejela zahtevek za začetek pregleda zaradi izteka ukrepa iz Uredbe (ES) št. 713/2005 v skladu s členom 18(2) osnovne uredbe. Družbi DSM in Sandoz (v nadaljnjem besedilu: vložnika) predstavljata večji delež, v tem primeru več kot 50 %, celotne proizvodnje Unije nekaterih antibiotikov širokega spektra.
The request was based on the grounds that the expiry of the measures would be likely to lead to a continuation or recurrence of subsidisation and injury to the Union industry.
Zahtevek je bil utemeljen s tem, da bi se zaradi izteka veljavnosti ukrepov verjetno nadaljevala ali ponovila subvencioniranje in škoda za industrijo Unije.
Prior to the initiation of the expiry review, and in accordance with Articles 10(9) and 22(1) of the basic Regulation, the Commission notified the Government of India (the GOI) that it had received a properly documented review request.
Pred začetkom pregleda zaradi izteka ukrepa ter v skladu s členoma 10(9) in 22(1) osnovne uredbe je Komisija obvestila indijsko vlado (v nadaljnjem besedilu: IV), da je prejela ustrezno dokumentiran zahtevek za pregled.
The GOI was invited for consultations with the aim of clarifying the situation as regards the contents of the request and arriving at a mutually agreed solution.
IV je bila povabljena na posvetovanje, da se pojasni položaj glede vsebine zahtevka in doseže sporazumna rešitev.
The GOI responded only very late to this invitation and, therefore, no such consultations have taken place.
IV se je na povabilo odzvala zelo pozno, zato do takih posvetovanj ni prišlo.
Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry review, the Commission announced on 12 May 2010, by a notice published in the Official Journal of the European Union [6] (the Notice of initiation), the initiation of an expiry review pursuant to Article 18 of the basic Regulation.
Komisija je po posvetovanju s svetovalnim odborom ugotovila, da obstajajo zadostni dokazi za začetek pregleda zaradi izteka ukrepa, zato je 12. maja 2010 z obvestilom, objavljenim v Uradnem listu Evropske unije [6] (v nadaljnjem besedilu: obvestilo o začetku), napovedala pregled zaradi izteka ukrepa v skladu s členom 18 osnovne uredbe.
The investigation of continuation or recurrence of subsidisation covered the period from 1 April 2009 to 31 March 2010 (‘the review investigation period’ or ‘RIP’).
Preiskava v zvezi z nadaljevanjem ali ponovitvijo subvencioniranja je zajela obdobje od 1. aprila 2009 do 31. marca 2010 (v nadaljnjem besedilu: obdobje preiskave v zvezi s pregledom ali OPP).
The examination of the trends relevant for the assessment of the likelihood of a continuation or recurrence of injury covered the period from 1 January 2007 to the end of the review investigation period (the period considered).
Proučitev gibanj, pomembnih za oceno verjetnosti nadaljevanja ali ponovitve škode, je zajela obdobje od 1. januarja 2007 do konca obdobja preiskave v zvezi s pregledom (v nadaljnjem besedilu: obravnavano obdobje).